Opaleye Management as of June 30, 2022
Portfolio Holdings for Opaleye Management
Opaleye Management holds 47 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Harrow Health (HROW) | 10.9 | $24M | 3.3M | 7.28 | |
| Ocular Therapeutix (OCUL) | 10.8 | $24M | 6.0M | 4.02 | |
| Codexis (CDXS) | 6.1 | $14M | 1.3M | 10.46 | |
| Crinetics Pharmaceuticals In (CRNX) | 5.6 | $13M | 671k | 18.65 | |
| Cytokinetics Com New (CYTK) | 5.4 | $12M | 303k | 39.29 | |
| Tela Bio (TELA) | 5.2 | $12M | 1.6M | 7.01 | |
| Protara Therapeutics Com Stk (TARA) | 4.0 | $8.9M | 2.7M | 3.31 | |
| Tracon Pharmaceuticals Com New | 3.7 | $8.3M | 4.1M | 2.00 | |
| Kiniksa Pharmaceuticals Com Cl A | 3.6 | $7.9M | 814k | 9.69 | |
| Merus N V (MRUS) | 3.4 | $7.7M | 338k | 22.64 | |
| Keros Therapeutics (KROS) | 3.4 | $7.6M | 276k | 27.63 | |
| Inhibrx | 3.0 | $6.7M | 590k | 11.35 | |
| Eton Pharmaceuticals (ETON) | 2.9 | $6.5M | 2.5M | 2.62 | |
| Xoma Corp Del Com New (XOMA) | 2.6 | $5.9M | 263k | 22.28 | |
| Reata Pharmaceuticals Class A | 2.5 | $5.6M | 184k | 30.39 | |
| Cutera (CUTR) | 2.5 | $5.5M | 148k | 37.50 | |
| Mersana Therapeutics (MRSN) | 2.2 | $4.8M | 1.0M | 4.62 | |
| Vaxcyte (PCVX) | 1.9 | $4.1M | 190k | 21.76 | |
| Stereotaxis Com New (STXS) | 1.7 | $3.9M | 2.1M | 1.84 | |
| Edgewise Therapeutics (EWTX) | 1.6 | $3.6M | 451k | 7.96 | |
| 908 Devices (MASS) | 1.5 | $3.4M | 166k | 20.59 | |
| Chimerix (CMRX) | 1.3 | $3.0M | 1.4M | 2.08 | |
| Fortress Biotech | 1.2 | $2.7M | 3.2M | 0.84 | |
| Celldex Therapeutics Com New (CLDX) | 1.1 | $2.4M | 90k | 26.96 | |
| Liquidia Corporation Com New (LQDA) | 1.0 | $2.3M | 522k | 4.36 | |
| 4d Molecular Therapeutics In (FDMT) | 1.0 | $2.3M | 325k | 6.98 | |
| Proqr Therapeutics Nv Shs Euro (PRQR) | 1.0 | $2.1M | 2.7M | 0.78 | |
| Urogen Pharma (URGN) | 0.9 | $2.0M | 239k | 8.19 | |
| Ginkgo Bioworks Holdings Class A Shares | 0.9 | $1.9M | 815k | 2.38 | |
| Verastem | 0.8 | $1.8M | 1.6M | 1.16 | |
| Larimar Therapeutics (LRMR) | 0.8 | $1.8M | 933k | 1.96 | |
| Hyperfine Com Cl A (HYPR) | 0.8 | $1.7M | 763k | 2.23 | |
| Rhythm Pharmaceuticals (RYTM) | 0.7 | $1.5M | 362k | 4.15 | |
| Modular Medical Com New (MODD) | 0.6 | $1.4M | 275k | 5.18 | |
| Impel Neuropharma | 0.6 | $1.3M | 145k | 9.32 | |
| Graphite Bio | 0.6 | $1.3M | 460k | 2.75 | |
| Journey Med Corp (DERM) | 0.4 | $919k | 246k | 3.74 | |
| Neoleukin Therapeutics | 0.3 | $628k | 610k | 1.03 | |
| Macrogenics (MGNX) | 0.3 | $614k | 208k | 2.95 | |
| Neuropace (NPCE) | 0.2 | $446k | 90k | 4.95 | |
| Forma Therapeutics Hldgs SHS | 0.2 | $404k | 59k | 6.88 | |
| Marinus Pharmaceuticals Com New (MRNS) | 0.2 | $333k | 69k | 4.83 | |
| Optinose (OPTN) | 0.2 | $333k | 91k | 3.66 | |
| Avalo Therapeutics | 0.1 | $225k | 450k | 0.50 | |
| Theseus Pharmaceuticals | 0.1 | $179k | 32k | 5.54 | |
| Lumos Pharma | 0.1 | $166k | 22k | 7.71 | |
| Biolinerx Sponsored Ads (BLRX) | 0.0 | $21k | 17k | 1.26 |
